Kitsada Wudhikarn, MD¹, Evandro Bezerra, MD², Yang Yang, MD³, Miguel-Angel Perales, MD⁴, Nitin Jain, MD⁵, Usama Gergis, MD, MBA³, Ahmed Aribi, MD^6*, LaQuisa Hill, MD^7*, Jessica T. Leonard, MD⁸, Forat Lutfi, MD⁹, Soyoung Kim, PhD^10*, Matthew Bye, MPH^10*, Zhen-Huan Hu, MPH^11*, Hai-Lin Wang, MPH^12*, Zhong-Cheng Luo, PhD^12*, Rubina Siddiqi, PhD^12*, Rita Damico Khalid, DO^12*, Jessica Speiser, MPH^12*, Marcelo C. Pasquini, MD, MS¹⁰, Partow Kebriaei, MD⁵ and Lori Muffly, MD¹³

¹Chulalongkorn University, Bangkok, Thailand
²The Ohio State University, Columbus, OH
³Thomas Jefferson University, Philadelphia, PA
⁴Memorial Sloan Kettering Cancer Center, New York, NY
⁵The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
⁷Baylor College of Medicine, Houston, TX
⁸Oregon Health & Science University, Portland, OR
⁹University of Kansas Health System, Kansas City, KS
¹⁰Center for International Blood and Marrow Transplant Research, Milwaukee, WI
¹¹Kite Pharma, a Gilead Company, Santa Monica, CA
¹²Kite, a Gilead Company, Santa Monica, CA
¹³Stanford University, Stanford, CA

Samantha A. Hershenfeld, MD, BSc^1*, Daniel McCormack, MSc^2*, Ning Liu, PhD^2* and Matthew C. Cheung, MD, MSc^1,2

¹Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
²ICES, Toronto, ON, Canada

Kimberly Ann Davidow, MD¹, Thomas Z Rohan, BS^2*, Cooper R Roslund^2*, Pierluigi Porcu³, Alan S Khoo, MBBS^4*, Christopher McNair, PhD^5*, AnneMarie C Brescia, MD^6* and Jonathan Powell, MD^7*

¹Lisa Dean Mosely Foundation Institute for Cancer and Blood Disorders, Nemours Children's Health - Delaware, Philadelphia, PA
²Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA
³Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PA
⁴Sidney Kimmel Cancer Center,, Thomas Jefferson University, Philadelphia, PA
⁵Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
⁶Nemours Children's Health - Delaware, Wilmington, DE
⁷Lisa Dean Mosely Foundation Institute for Cancer and Blood Disorders, Nemour's Children's Health - Delaware, Wilmington, DE

Jean-Nicolas Champagne, MD¹, Steven Huang, BSc^2*, Rayan Ramadan^3*, Christopher P. Venner, MD⁴, Khaled Ramadan, FRCPath^5*, Laurie H. H. Sehn, MD⁴, Kerry J. Savage, MD, MSc⁶, Diego Villa, MD⁷, David W. Scott, MBChB, PhD⁸, Waleed Alduaij, PhD, MBChB⁹, Cynthia L. Toze, MD, MSc, FRCPC¹⁰ and Alina S. Gerrie, MD, MPH⁴

¹BC Cancer Vancouver, Vancouver, BC, Canada
²Vancouver General Hospital, Vancouver, BC, CAN
³Providence Health Care Research Institute, Vancouver, BC, Canada
⁴Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
⁵St. Paul's Hospital Providence Health Care, Vancouver, BC, CAN
⁶Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada
⁷Centre for Lymphoid Cancer, BC Cancer – Vancouver Cancer Centre, Vancouver, BC, Canada
⁸Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada
⁹British Columbia Cancer Research Insitute, Vancouver, BC, Canada
¹⁰Leukemia/Bone Marrow Transplant Program of British Columbia, British Columbia Cancer Agency, Vancouver, Canada

William Schwartzman, MD¹, Ang Gao, MS^2*, Chul Ahn, PhD^2*, Heather R Wolfe, MD^3,4*, Praveen Ramakrishnan Geethakumari, MD, MS⁴, Farrukh T. Awan, MD⁵ and Elif Yilmaz, MD⁶

¹Harold C. Simmons Comprehensive Cancer Center, UT Southwestern, Irving, TX
²Peter O’Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, TX
³University of Texas Southwestern Medical Center, Dallas, TX
⁴Section of Hematological Malignancies and Cellular Therapy, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX
⁵Southwestern Medical Center, Harold C. Simmons Comprehensive Cancer Center, The University of Texas, Dallas, TX
⁶Hematologic Malignancies and Cellular Therapy, University of Texas Southwestern Medical Center, Dallas, TX

Tycel J. Phillips, MD¹, Alexey V. Danilov, MD, PhD², Jia Ruan³, Krish Patel, MD^4*, Anita Kumar, MD⁵, Yucai Wang, MD, PhD⁶, Gregory A. Maglinte^7*, Erlene Seymour^7* and Manali Kamdar, MD, MBBS^8*

¹City of Hope, Duarte, CA
²City of Hope National Medical Center, Duarte, CA
³Weill Cornell Medicine, New York, NY
⁴Swedish, Seattle, WA
⁵Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Mayo Clinic, Rochester, MN
⁷BeiGene, San Mateo, CA
⁸University of Colorado, Boulder, CO

Mrinal Joshirao, MD¹, Lilibeth Torno, MD^2,3*, Carol Hwang Lin, MD², Arun Ranjan Panigrahi, MD⁴, Robert Raphael, MD^5*, Griselda Alvarez, MD, HS^6,7*, Robert Goldsby, MD^8* and Dennis John Kuo, MD, MS^9*

¹Rady Children's Hospital, University of California San Diego, San Diego, CA
²Division of Oncology, Hyundai Cancer Institute, Children's Hospital of Orange County, Orange, CA
³University of California, Irvine School of Medicine, Orange, CA
⁴University of California - Davis, Sacramento, CA
⁵UCSF Benioff Children’s Hospital Oakland, Oakland, CA
⁶Endocrine and Diabetes Center, Miller Children's Hospital Long Beach, Long Beach, CA
⁷Pediatric Endocrinology, David Geffen School of Medicine at UCLA, Los Angeles, CA
⁸UCSF Benioff Children's Hospital, San Francisco, CA
⁹Rady Children's Hospital, San Diego, CA

Paul J. Hampel, MD¹, Ying Huang, MS, MA², Sarah Miller, BS^3*, John N. Allan, MD⁴, Seema A Bhat, MD⁵, David A. Bond, MD, BS⁵, Danielle M. Brander, MD⁶, John C. Byrd, MD⁷, Julio C. Chavez, MD⁸, Elise A. Chong, MD⁹, Alexey Danilov, MD, PhD¹⁰, Matthew S. Davids, MD, MMSc¹¹, Kaitlyn M. Dvorak-Kornaus, PhD^5*, Hannah Freedman, RN^12*, Nikita Malakhov, MD¹³, Matthew Matasar, MD, MS¹⁴, Cecelia Miller, PhD¹⁵, Sameer A. Parikh, MBBS¹⁶, Erin M. Parry, MD, PhD¹⁷, Kari G. Rabe, MS^18*, Phil Raess, MD, PhD^19*, Manoj Rai, MD^20*, Joanna M. Rhodes, MD²¹, Kerry A. Rogers, MD⁵, Aditi Saha, MBBS²², Jake Schade, BA^23*, Geoffrey Shouse, PhD, DO²⁴, Stephen E Spurgeon, MD²⁵, Deborah M. Stephens, DO²⁶, Yucai Wang, MD, PhD¹⁶, Jennifer A. Woyach, MD²⁷, Max Yano, MD, PhD^28*, Omer Zulfa^29* and Adam S Kittai, MD³⁰

¹Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
²Division of Hematology, Department of Statistics, The Ohio State University Wexner Medical Center, Columbus, OH
³Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
⁴Division of Hematology and Oncology, Weill Cornell Medicine, Long Island City, NY
⁵Division of Hematology, The Ohio State University, Columbus, OH
⁶Duke University, Durham, NC
⁷Department of Internal Medicine, University of Cincinnati, Cincinnati, OH
⁸Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Lutz, FL
⁹Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
¹⁰City of Hope Comprehensive Cancer Center, La Canada Flintridge, CA
¹¹Department of Medical Oncology, Dana-Farber Cancer Institute, Inc., Boston, MA
¹²Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
¹³Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY
¹⁴Division of Blood Disorders, Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, New York, NY
¹⁵Division of Pathology, The Ohio State University, Columbus, OH
¹⁶Division of Hematology, Mayo Clinic, Rochester, MN
¹⁷Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹⁸Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
¹⁹Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR
²⁰Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR
²¹Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
²²Department of Hematology/Oncology, Moffitt Cancer Center, West Orange, NJ
²³Rutgers Cancer Institute, New Brunswick, NJ
²⁴City of Hope Cancer Center, Duarte, CA
²⁵Knight Cancer Institute, Oregon Health & Science University, Portland, OR
²⁶University of North Carolina Chapel Hill, Chapel Hill, NC
²⁷Division of Hematology, Ohio State University Comprehensive Cancer Center, Columbus, OH
²⁸College of Medicine, The Ohio State University, Columbus, OH
²⁹University of Cinncinati, Cincinatti, OH
³⁰Icahn School of Medicine at Mount Sinai, New York, NY

Inna Y Gong, MD, PhD¹, Bahar Rafinejad-Farahani, MPH^2*, Haris Majeed^2*, Mark Soto, MSc^3*, Rena M Conti, PhD^4*, Joseph M Unger, PhD^5*, Carmen E Guerra, MD^6*, Meredith Rosenthal, PhD^7* and Danielle Rodin, MD, MPH^8*

¹Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
²Global Cancer Program, Princess Margaret Cancer Centre, Toronto, ON, Canada
³Department of Health Policy and Management, Harvard T. H. Chan School of Public Health,, Boston, MA
⁴Department of Markets, Public Policy, and Law, Boston University Questrom School of Business, Boston, MA
⁵Fred Hutchinson Cancer Research Center, Seattle
⁶Division of General Medicine, Department of Medicine,Hospital of the University of Pennsylvania, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
⁷Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, MA
⁸Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada

Paul A. Hamlin, MD¹, Pallawi Torka, MD¹, Eric Hansen, MS^2*, Andrew J. Belli, MPH^2*, Jacob Ambrose, MS^2*, Christina M. Zettler, MPH^2*, Laura L. Fernandes, PhD², Stephanie Wiley, RN, OCN^2*, Brittney Perry, RN, OCN^2* and Ching-Kun Wang, MD^2*

¹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²COTA, Inc., New York, NY

Heidi Cho, MD¹, Kausik Maiti, MD^2*, Nancy Lunney, MA^3*, Vladimir Otasevic, MD^4* and Chris Learn, PhD^3*

¹Parexel, Denver, CO
²Parexel, , Durham, NC
³Parexel, Durham, NC
⁴Clinic for Hematology, University Clinical Center of Serbia, Belgrade, Serbia

Moazzam Shahzad, MD¹, Eeman Ahmad^2*, Shahzaib Ahmed^2*, Umar Akram^3*, Shoaib Ahmad^4*, Muhammad Kashif Amin, MD^5*, Fatima Tuz Zahra, MBBS⁶, Muhammad Umair Mushtaq^5,7 and Michael V. Jaglal, MD⁸

¹Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
²Fatima Memorial Hospital College of Medicine and Dentistry, Lahore, Pakistan
³Allama Iqbal Medical College, Lahore, Pakistan
⁴Punjab Medical College, Faisalabad, Pakistan
⁵Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
⁶H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
⁷Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
⁸Department of Hematology/Oncology, Moffitt Cancer Center, Tampa, FL

Mahek Garg, PhD¹, Ambika Satija, PhD^2*, Yan Song, PhD^2*, Ben Meade, BA^3*, James Signorovitch, PhD^2* and Shravanthi Gandra, PhD, MBA^4*

¹Merck Sharp & Dohme LLC, Rahway, NJ
²Analysis Group, Inc., Boston, MA
³Analysis Group, Inc, Paris, France
⁴Merck & Co., Inc., Rahway, NJ

Brittaney-Belle Elizabeth Gordon, MD^1,2, Svea K. Wahlstrom, VMD, MS^3*, Anna Teschemaker, PhD^1*, Rachel H. Mackey, PhD, MPH^4*, Diana DeVincenzo, PharmD^3*, Leslie A. Carabuena, MSIE^4*, Samantha L. Thompson, PhD^5*, Ning A. Rosenthal, MD, PhD^4* and Javid J. Moslehi, MD^6*

¹AstraZeneca, Gaithersburg, MD
²University of Pittsburgh Medical Center (UPMC), Hillman Comprehensive Cancer Center, Pittsburgh, PA
³AstraZeneca, Wilmington, DE
⁴Premier Inc, PINC AI Applied Sciences, Charlotte, NC
⁵AstraZeneca, Cambridge, United Kingdom
⁶Section of Cardi-Oncology & Immunology, University of California San Francisco, San Francisco, CA

Arshi Syal, MD^1,2, Yajur Arya, MD^1,2, Karecia Byfield, MBBS^1,2*, Bruce Adrian Casipit, MD^1,2*, Claudia Dourado, MD^1,2 and Gabor Varadi, MD^1,2*

¹Albert Einstein Medical Center, Philadelphia, PA
²Thomas Jefferson University Hospital, Philadelphia, PA

Ayse Levent, MSc^1*, Angelena Moseley^2*, Rebecca Simons^3* and Serafina Adabra^4*

¹Ipsos, New York, NY
²Ipsos Insight, LLC, Ambler, PA
³Ipsos Insight, LLC, Boston, MA
⁴Ipsos Insight, LLC, London, United Kingdom

Yo Saito, MD^1*, Tetsuro Oda, MSc^2*, Shimpei Nakanishi, BA^2*, Minoru Ota, BA^2*, Naoki Maeda, MSc^2*, Daisuke Kozuka, MSc^2* and Noriko Fukuhara, MD, PhD³

¹Department of Hematology, Miyagi Cancer Center, Natori, Japan
²Drug Safety Division, Chugai Pharmaceutical Co., Ltd., Chuo-Ku, Japan
³Department of Hematology, Tohoku University School of Medicine, Sendai, Japan

Javid J. Moslehi, MD^1*, Svea K. Wahlstrom, VMD, MS^2*, Anna Teschemaker, PhD^3*, Rachel H. Mackey, PhD, MPH^4*, Diana DeVincenzo, PharmD^2*, Leslie A. Carabuena, MSIE^4*, Samantha L. Thompson, PhD^5*, Brittaney-Belle Elizabeth Gordon, MD^3,6 and Ning A. Rosenthal, MD, PhD^4*

¹Section of Cardi-Oncology & Immunology, University of California San Francisco, San Francisco, CA
²AstraZeneca, Wilmington, DE
³AstraZeneca, Gaithersburg, MD
⁴Premier Inc, PINC AI Applied Sciences, Charlotte, NC
⁵AstraZeneca, Cambridge, United Kingdom
⁶University of Pittsburgh Medical Center (UPMC), Hillman Comprehensive Cancer Center, Pittsburgh, PA

Jason M Stevenson, MD^1,2*, Anjali Khanna, MBBS, MPH^1,2*, Ashleigh Hawk, MPH^1,2*, Avery Morse^1,2*, Oyin Alao, MPH^1,2*, Katherine Jordan^1,2*, Xu Ji, PhD^1,2,3, Heeju Sohn, PhD^4*, Sharon M. Castellino, MD, MSc^1,2 and Tamara P. Miller, MD^1,5

¹Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
²Department of Pediatrics, Division of Hematology, Oncology, and Bone Marrow Transplant, Emory University School of Medicine, Atlanta, GA
³Department of Health Policy and Management, Emory University Rollins School of Public Health, Atlanta, GA
⁴Department of Sociology, Emory University, Atlanta, GA
⁵Department of Pediatrics, Division of Hematology, Oncology, and Bone Marrow Transplant, Emory University School of Medicine, Decatur, GA

Francesco Iadevaia, MD^1*, Ramsay Hafer, BS^2*, Thomas Z Rohan, BS^3*, Alan Khoo, MBBS^3,4*, Luca Laurenti, MD^5* and Pierluigi Porcu, MD^4,6

¹Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica Del Sacro Cuore, Roma, Italy
²Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA
³Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA
⁴Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA
⁵Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Universitaria Policlinico Agostino Gemelli, Rome, Italy
⁶Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA

Hazim Ababneh, MD¹, Andrea Ng, MD, MPH^2*, Andrzej Niemierko, PhD^1*, Matthew Frigault, MD, MS³, Caron A. Jacobson, MD, MMSc⁴ and Chirayu Patel, MD, MPH^1*

¹Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
²Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA
³Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA
⁴Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Inna Y Gong, MD, PhD¹, Meredith Rosenthal, PhD^2*, Mark Soto, MSc^3*, Bahar Rafinejad-Farahani, MPH^4*, Joseph M Unger, PhD^5*, Carmen E Guerra, MD^6*, Rena M Conti, PhD^7* and Danielle Rodin, MD, MPH^8*

¹Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
²Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, MA
³Department of Health Policy and Management, Harvard T. H. Chan School of Public Health,, Boston, MA
⁴Global Cancer Program, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁵Fred Hutchinson Cancer Research Center, Seattle
⁶Division of General Medicine, Department of Medicine,Hospital of the University of Pennsylvania, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
⁷Department of Markets, Public Policy, and Law, Boston University Questrom School of Business, Boston, MA
⁸Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada

Joanna M. Rhodes, MD, MSCE^1*, Naleen Raj Bhandari, Ph.D^2*, Manoj Khanal, Ph.D^2*, Dan He, M.Sc^3*, Sarang Abhyankar, MD, Ph.D², John M. Pagel, MD, Ph.D, DSc², Lisa M. Hess, Ph.D^2* and Alan P Skarbnik, MD⁴

¹Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
²Eli Lilly and Company, Indianapolis, IN
³Syneos Health, Morrisville, NC
⁴Novant Health Cancer Institute, Charlotte, NC

Zixun Yan^1*, Dehui Zou^2*, Wenbin Qian^3*, Ying Lu^4*, Yuhua Li^5*, Dongmei Ji^6*, Xiaojian Zhu^7*, Heng Mei, md, phd^8*, Ping Li^9*, Changju Qu, MD, PhD^10*, Lei Zhang^11*, Keshu Zhou^12*, Hongmei Jing^13*, Ting Niu, MD, PhD¹⁴, Chunyan Ji¹⁵, Lanfang Li^16*, Hua Yang^17*, Fei Li¹⁸, Wei Wang^19*, Kailin Xu^20*, Jinghua Zhao^21*, Depei Wu, MD, PhD²², Yu Hu^8* and Weili Zhao¹

¹Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
²State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
³Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
⁴Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China
⁵Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
⁶Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
⁷Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁸Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁹Department of Hematology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China
¹⁰The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China
¹¹Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
¹²Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
¹³Department of Hematology and Lymphoma Research Center, Peking University Third Hospital, Beijing, China
¹⁴Department of Hematology, West China Hospital, Sichuan University, Chengdu, China
¹⁵Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
¹⁶Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma, Tianjin, China
¹⁷Department of Hematology, Hongkong University-Shenzhen Hospital, Shenzhen, China
¹⁸Center of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China
¹⁹Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China
²⁰Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
²¹Department of Clinical Development & Medical, Fosun Kite Biotechnology Co. Ltd., Shanghai, China
²²Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China

Mengyang Di, MD, PhD¹, Carrie I Ho, MD², Stephen D. Smith, MD², Mazyar Shadman, MD, MPH^2,3, Chaitra S. Ujjani, MD², Ryan C. Lynch, MD⁴, Christina Poh, MD², Vikram Raghunathan, MD^2*, Brian G. Till, MD^2,4, Edus H. Warren, MD, PhD^2,5, Ajay K. Gopal, MD¹ and Stephanie J. Lee, MD, MPH³

¹University of Washington, Seattle, WA
²Division of Hematology and Oncology, University of Washington, Seattle, WA
³Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
⁴Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
⁵Fred Hutchinson Cancer Center, Seattle, WA

Tammarah Sklarz, MD¹, Tesla DuBois, MS^2,3* and Shannon Lynch, PhD^2,4*

¹Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA
²Fox Chase Cancer Center Division of Cancer Prevention and Control, Philadelphia, PA
³Temple University Geography and Urban Studies, Philadelphia, PA
⁴Temple University School of Medicine Center for Biostatistics and Epidemiology, Philadelphia, PA

Jia Yi Tan, MD¹, Yong Hao Yeo, MBBS^2*, Qi Xuan Ang, MBBS^3*, George Chen, MD⁴ and Kok Hoe Chan, MD⁵

¹Department of Internal Medicine, Saint Michael's Medical Center, Newark, NJ
²Department of Internal Medicine/Pediatrics, Corewell Health, Royal Oak, MI
³Department of Internal Medicine, Sparrow Health System and Michigan State University, East Lansing, MI
⁴Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Charleston Area Medical Center, Charleston, WV

John L Vaughn, MD, MS¹ and Narendranath Epperla, MD, MS²

¹NYU Grossman Long Island School of Medicine, Mineola, NY
²Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

Gilad Itchaki, MD^1,2*, Talish Razi, MPH^3*, Adi Zoref-Lorenz, MD⁴, Martin H. Ellis, MD^1,2* and Ronen Arbel, PhD^3,5*

¹Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
²Hematology Institute, Meir Medical Center, Kfar Saba, Israel
³Community Medical Services Division, Clalit Health Services, Tel Aviv, Israel
⁴Hematology Institute, Meir Medical Center, Faculty of Medicine, Tel Aviv University, KFAR-SABA, Israel
⁵Maximizing Health Outcomes Research Lab, Sapir College, Sderot, Israel

Kunhwa Kim, MD¹, Amy Ayers, MPH^2*, Sairah Ahmed, MD², Linda Claret^2*, Paolo Strati, MD², Ranjit Nair, MD^2*, Chijioke Nze, MD, MPH², Jeremy Ramdial, MD³, Janet Torres^3*, Elizabeth J. Shpall, MD³, Luis E. Fayad, MD⁴, Loretta Nastoupil^2*, Jason R. Westin, MD², Christopher R. Flowers, MD, MS², Sattva S. Neelapu, MD² and Dai Chihara, MD, PhD²

¹Division of Cancer Medicine, The University of Texas MD Anderson, Houston, TX
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴The University of Texas MD Anderson Cancer Center, Houston, TX

Abraham Mullasseril Varghese, MBBS, MRCP , PhD^1,2, Lauren Wright, MSc^3*, Talha Munir, MBBS, PhD⁴, Russell Patmore, FRCPath⁵, Catherine Parbutt^6* and Alexandra Smith, PhD^7*

¹Department of Haematology, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
²Department of Haematology, St James's University Hospital, Leeds, United Kingdom
³University of York, York, United Kingdom
⁴Department of Haematology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
⁵Hull University Teaching Hospitals NHS trust, Driffield, ENG, GBR
⁶Leeds teaching hospitals NHS trust, Leeds, GBR
⁷Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom

Michael Schneider, MD, PhD¹, Elise A. Chong, MD¹, Stefan K. Barta, MD¹, Sunita D. Nasta, MD¹, Jakub Svoboda, MD¹, Jordan Carter, MD^1*, Michael Roderick Cook, MD¹, Nasheed Hossain, MD^1*, Stephen J. Schuster, MD¹, Heather Difilippo, CRNP^1*, John P Plastaras, MD, PhD^1*, Michael Lariviere, MD^1*, Marco Ruella, MD², David L. Porter, MD¹, Noelle Frey, MD, MS³ and Daniel J. Landsburg, MD¹

¹School of Medicine, Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA
²Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
³University of Pennsylvania, Philadelphia, PA

Shlomzion Aumann^1*, Abraham Avigdor, MD², Ronit Marcus, MD^2*, Netanel A. Horowitz, MD^3,4*, Ronit Gurion^5*, Tamar Tadmor, MD^6*, Roy Vitkon, MD^7*, May Meira Basood, MD^8*, Uri Abadi, MD^9* and Meirav Kedmi, MD^2*

¹Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
²Division of Hematology & Bone marrow transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel, School of Medicine, Tel-Aviv University, Tel Aviv, Israel
³Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
⁴Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
⁵Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center & Faculty of Medicine and Health Sciences, Tel-Aviv University, Tel Aviv, Israel
⁶Hematology Unit, Bnai Zion Medical Center, Haifa, Israel
⁷Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
⁸Assuta hospital, Tel Aviv, Israel
⁹Hematology Institute, Meir Medical Center, Kfar Saba, Israel

Matthew Newman, MD¹, Zimin Zhuang, MS^2*, Chun R. Chao, PhD, MS^3* and Robert Cooper, MD^4*

¹Department of Internal Medicine, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA
²Department of Research & Evaluation, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA
³Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA
⁴Department of Pediatric Hematology/Oncology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA

Serif Sungur, BMedSci (Hons)^1*, Yao Yao, MBBS^2*, Cameron Wellard, BSc (Hons), PhD^3*, Eliza Chung, BSc, MPH^4*, Susan Morgan, MBBS, FRACP, FRCPA^5*, Denise Lee, MBBS, FRACP, FRCPA^6*, Geoffrey Chong^7,8, Chan Y. Cheah, MBBS DMSc⁹, Tasneem Rizvi^10*, Eliza A. Hawkes, MD^11,12, Zoe K McQuilten, MBBS, PhD¹³, Erica M. Wood, MD¹⁴, Nada Hamad, MBBS, MSc, BSc^15,16,17, Tasman Armytage, MBBS, BSc, FRACP, FRCPA^2* and Anna M. Johnston, FRACP, MBBS, FRCPA^18,19

¹School of Medicine, University of Tasmania, Launceston, TAS, Australia
²Gosford Hospital, Gosford, Australia
³School of Public Health and Preventative Medicine, Monash University, Melbourne, VIC, Australia
⁴Monash University, Melbourne, AUS
⁵Alfred Health, Melbourne, VIC, Australia
⁶Austin Hopsital, Melbourne, Australia
⁷Olivia Newton-John Cancer Wellness & Research Centre, Austin Hospital, Heidelberg, VIC, Australia
⁸Ballarat Regional Integrated Cancer Centre, Ballarat Central, VIC, Australia
⁹Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
¹⁰Department of Haematology, Royal Hobart Hospital, Hobart, Australia
¹¹School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
¹²Austin Health, Olivia Newton John Cancer Research Institute, Heidelberg, VIC, Australia
¹³Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
¹⁴Monash University, Melbourne, Australia
¹⁵St Vincent's Hospital, Sydney, NSW, Australia
¹⁶School of Clinical Medicine, Faculty of Medicine and Health, The University of New South Wales, Sydney, NSW, Australia
¹⁷School of Medicine, University of Notre Dame, Sydney, Australia
¹⁸Royal Hobart Hospital, Hobart, Australia
¹⁹University of Tasmania, Hobart, Australia

Rishab Prakash, BS^1*, James Long, PhD^2*, Benjamin Mescher^3*, Paul Edelkamp Jr.^4*, Mark Knafl, MS^5*, Jeff Jin^6*, Trey Kell^7*, Naveen Garg, MD^8*, Ajlan Al Zaki, MD, PhD⁹, Dai Chihara, MD, PhD¹, Luis Malpica, MD^1*, Ranjit Nair, MD^1* and Swaminathan P Iyer, MD^1*

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
³MD Anderson Cancer Center, Houston, TX
⁴Department of Enterprise Data Engineering & Analytics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶M.D. Anderson Cancer Center, Houston, TX
⁷MD Anderson Cancer Center, Texas, TX
⁸Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Lymphoma/Myeloma and Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

Karan Gowda, MPH^1,2*, Medha Gupta^2,3*, Adrian Aguliar^2,4*, Carlos Cruz^2,5*, Elizabeth Rodriguez⁶, Sairah Ahmed, MD⁷, Branko Cuglievan, MD⁸, Efstratios Koutroumpakis, MD^9*, Michael E. Roth, MD⁸ and Michelle A.T. Hildebrandt, PhD¹⁰

¹Chicago Medical School, North Chicago
²University of Texas MD Anderson Cancer Center, Houston
³Drexel University College of Medicine, Philadelphia
⁴Macalester College, St. Paul
⁵Rice University, Houston
⁶The University of Texas MD Anderson Cancer Center, Houston
⁷Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Division of Pediatrics, MD Anderson Cancer Center, Houston, TX
⁹University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Vinod Kumar, MBBS^1*, Shaykhah Alotaibi, MD^2*, Zhuo Li, MS^3*, Ernesto Ayala, MD¹, Mohamed A. Kharfan-Dabaja, MD, MBA¹ and Madiha Iqbal, MD⁴

¹Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
²Dept of Hematology, Stem Cell Transplantation and Cellular Therapy , KFSHRC, Riyadh, Saudi Arabia
³Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville
⁴Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL

Rahela Aziz-Bose, MD^1,2,3,4, Lucille Lokko, BA^4*, Morgan A. Paul, MS^5*, Colleen A. Kelly, MD^3,4, Leanne Duhaney, MD, MPH^6*, Puja J. Umaretiya, MD^7*, Fang Fang Zhang, MD, PhD^8*, Lisa B. Kenney, MD^2,3,4* and Kira Bona, MD, MPH^2,3,4,9

¹Division of Population Sciences, Dana-Farber Cancer Institute, Jamaica Plain, MA
²Department of Pediatrics, Harvard Medical School, Boston, MA
³Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA
⁴Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
⁵Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁶Department of Cardiology, Boston Children's Hospital, Boston, MA
⁷Division of Pediatric Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX
⁸Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA
⁹Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA

Shubham Adroja, MBBS¹, Ethan A Burns, MD¹, Noah Giese, MD, MEng^2*, Sunil Mathur^1*, Meera Khosla, MD^2*, Jacqueline Rios^2*, Hala S Hassanain, MD^3*, Premal D. Lulla, MBBS⁴, Carlos A. Ramos, MD^2,5, Carrie Yuen, MD^1*, Chih-Hang Anthony Tang, MD, PhD⁶, Chih-Chi Andrew Hu, PhD⁷, Siddhartha Ganguly, MD², Helen Elisabeth Heslop⁸ and Sai Ravi Kiran Pingali, MD¹

¹Houston Methodist Neal Cancer Center, Houston Methodist Hospital, Houston, TX
²Houston Methodist Hospital, Houston, TX
³Internal Medicine, Department of Academic Medicine, Houston, TX
⁴Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital, Houston, TX
⁵Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital, Houston, TX
⁶Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX
⁷Houston Methodist Research Institute, Houston, TX
⁸Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX

Gareth P. Gregory, MBBS(Hons), PhD¹, Jeremy S. Abramson, MD², Hui-Qiang Huang^3*, Qing-Yuan Zhang^4*, Matthew Ku, MBBS, PhD^5*, Dok Hyun Yoon, MD, PhD⁶, Christopher P. Fox, MBChB(Hons), PhD, FRCP⁷, Haifaa Abdulhaq⁸, William Townsend^9*, Joan Ashby^10*, Alana Harris^11*, Victor Orellana-Noia^10*, Stephen Simko^10*, Martine Kallemeijn^12*, Richard Ta^10*, James Relf^11*, Huang Huang, MSc^13*, Linda Lundberg^12* and Huilai Zhang, MD¹⁴

¹School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia
²Massachusetts General Hospital Cancer Center, Boston, MA
³Sun Yat-Sen University Cancer Center, Guangzhou, China
⁴Harbin Medical University Cancer Hospital, Harbin, China
⁵St Vincent's Hospital, University of Melbourne, Melbourne, Australia
⁶Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁷School of Medicine, University of Nottingham, Nottingham, United Kingdom
⁸University of California San Francisco, Fresno Campus, California, CA
⁹University College London Hospitals, London, United Kingdom
¹⁰Genentech, Inc., South San Francisco, CA
¹¹Roche Products Ltd, Welwyn Garden City, United Kingdom
¹²F. Hoffmann-La Roche Ltd, Basel, Switzerland
¹³Hoffmann-La Roche Ltd, Mississauga, ON, Canada
¹⁴Tianjin Medical University Cancer Institute, Tianjin, China

Vincenzo J Pizzuti, MD, MSc^1*, Kaitlyn Hoover, MS^2*, Jamie L Studts, PhD^3*, Tyler W. Buckner, MD, MSc⁴, Benjamin Brewer, PsyD^1* and Ajay Major, MD, MBA¹

¹Division of Hematology, University of Colorado School of Medicine, Aurora, CO
²University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, CO
³Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO
⁴Hemophilia and Thrombosis Center, University of Colorado School of Medicine, Aurora, CO

Tiana Kordbacheh, MBBS, PhD, BSc¹, Anca Prica, MD, MSc^1,2*, Kelvin KW Chan, MD, PhD^3*, Mahmood Aminilari, PhD^4*, Zharmaine Ante^5*, Ning Liu, PhD^6*, Inna Y Gong, MD, PhD^1,2, Sita Bhella, MD^1,2*, Michael Crump, MD^1,2*, Abi Vijenthira, MD, SM^2,7, John Kuruvilla, MD, FRCPC^2,8, Robert Kridel, MD, PhD^1,2, Christine I Chen, MHPE, MD^2,9, Vishal Kukreti, MD, MSc^2,7, Chloe Yang, MD^2,10*, Nauman Malik^4,11*, David Hodgson, MD^4,11* and Danielle Rodin, MD, MPH^4,11*

¹Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
²Department of Medicine, University of Toronto, Toronto, ON, Canada
³Division of Hematology and Oncology, Department of Medicine, University of Toronto, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
⁴Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada
⁵Research & Analysis, ICES, Toronto, ON, Canada
⁶ICES, Toronto, ON, Canada
⁷Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁸Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁹Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
¹⁰Princess Margaret Cancer Centre, Toronto, ON, Canada
¹¹Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada

John Sharp, MD¹, Rina Li Welkie, MPH², Lexus Frazier, PharmD, BCOP^3*, Timothy Voorhees, MD, MSc⁴, Polina Shindiapina, MD, PhD^4*, Robert Baiocchi, MD, PhD¹ and Ashley Rosko, MD⁵

¹James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
²The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH
³Department of Pharmacy, The James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH
⁴Division of Hematology, The Ohio State University, Columbus, OH
⁵The Ohio State University, Columbus, OH

Elisabet Viayna, PhD^1*, Miriam Haviland^2*, Jiani Zhou^3*, Michelle McCrory^4*, Edward CaJacob^3*, Kim Hanna^3*, James Jordan, PharmD^5* and Elisabeth Calderón-Gómez^6*

¹Grifols, Sant Cugat Del Vallès, AL, Spain
²IQVIA, Durham, NC
³Grifols, Durham
⁴Grifols, Dublin, Ireland
⁵Grifols, Research Triangle Park, NC
⁶Grifols, Sant Cugat del Valles, Spain

Chun-Kai Liao, MD^1*, Chia-Jen Liu, MD, PhD^2,3,4, Tran-Der Tan⁵, Ming-Chung Wang^6*, Ya-Ting Hsu^7*, Hung-Lin Liu^8*, Shang-Ju Wu^9*, Hsueh-Ju Lu^10*, Jeng-Shiun Du, MD^11*, Wan-Jhen Gao, MD^12* and Cheng-Chih Tsai^13*

¹Hematology-oncology, E-DA Dachang Hospital, I-Shou University,, Kaohsiung, Taiwan
²Taipei Veterans General Hospital, Taipei, Taipei (City), TWN
³Taipei Veterans General Hospital, Taipei, Taipei (city), TWN
⁴Taipei Veterans General Hospital, Taipei, TWN
⁵Koo Foundation Sun Yat Sen Cancer Center, Taipei City, Taiwan
⁶Chang Gung Memorial Hospital, Kaohsiung, Taiwan
⁷National Cheng Kung University Hospital, Taiwan, R.O.C., TWN
⁸Kaohsiung-Chang Gang Memorial Hospital, Kaohsiung, TWN
⁹Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
¹⁰Division of Hematology and Oncology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
¹¹Division of Hematology/Oncology, department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
¹²Division of Hematology-Oncology, Chi Mei Medical Center, Tainan, TWN
¹³Division of Hematology and Oncology, Taitung MacKay Memorial Hospital, Taitung, Taiwan